Prevalence of lymphoma subtypes in Shanxi according to latest WHO classification

Chinese Journal of Pathology

Volumn 35, Issue 4, 2006, Pages 218-223

  Wang, Jin Fen ^a   Wang, Yun Zhong ^c   Chen, Zhen Wen ^c   Taylor, Clive R ^b  

^a SHANXI TUMOR HOSPITAL   (China)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c NONE

Author keywords

Classification; Histology, comparative; Lymphoma

Indexed keywords

CD15 ANTIGEN; CD20 ANTIBODY; CD23 ANTIGEN; CD3 ANTIGEN; CD30 ANTIGEN; CD4 ANTIGEN; CD5 ANTIGEN; CD56 ANTIGEN; CD7 ANTIGEN; CD79A ANTIGEN; CD8 ANTIGEN; CD99 ANTIGEN; CHLORDANE; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLIN D1; IMMUNOGLOBULIN D; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; LEUKOSIALIN; PROTEIN BCL 6; T6 ANTIGEN; TRANSCRIPTION FACTOR PAX5;

ANAPLASTIC CARCINOMA; ARTICLE; B CELL LYMPHOMA; CANCER CLASSIFICATION; CELL LINEAGE; CONTROLLED STUDY; FOLLICULAR LYMPHOMA; HERPES; HISTIOCYTIC LYMPHOMA; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LARGE CELL LYMPHOMA; LYMPHOBLASTOMA; LYMPHOMA; MAJOR CLINICAL STUDY; MANTLE CELL LYMPHOMA; NATURAL KILLER T CELL; NONHODGKIN LYMPHOMA; PREVALENCE; PROTEIN EXPRESSION; T CELL LYMPHOMA; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CHINA; FEMALE; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; LYMPHOMA; LYMPHOMA, FOLLICULAR; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PREVALENCE; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 33744502905     PISSN: 05295807     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. Cancer J Clin, 1999, 49:33-64.
2. Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin' s Lymphoma Classification Project. Ann Oncol, 1998, 9:717-720.
3. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasm: a proposal from the International Lymphoma Study Group. Blood, 1994, 84:1361-1392.
4. Jaffe ES, Harris NL, Stein H, et al. World Health Organization classification of tumors. Pathology & genetics. Tumors of haematopoietic and lymphoid tissue. Lyons: IARC Press, 2001. 215-289.
5. Shi Sh-R, Guo J, Taylor CR, et al. Antigen Retrieval Techniques: Immunohistochemistry and molecular morphology. Natick: Eaton Publishing, 2002. 311-353.
6. Wang JF, Taylor CR. Apoptosis and cell cycle-related genes and proteins in classical Hodgkin lymphoma: application of tissue microarray technique. AIMM, 2003, 11:206-213.
7. [No authors listed]. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood, 1997, 89:3909-3918.
8. Naresh KN, Agarwal B, Nathwani B, et al. Use of the World Health Organization (WHO) classification of Non-Hodgkin's lymphoma in Mombay? India: a review of 200 consecutive cases by a panel of five expert hematopathologists. Leukemia Lymphoma, 2004, 45:1569-1577.
9. Turner JJ, Hughes AM, Kricker A, et al. Use of the WHO lymphoma classification in a population-based epidemiological study. Ann Oncol, 2004, 15:631-637.
10. Harris NL, Jaffe ES, Diebold J, et al. Lymphoma classification-from controversy to consensus: the REAL and WHO classification of lymphoid neoplasms. Ann Oncol, 2000, 11 (Suppl 1):3-10.
11. Lymphoma Study Group of Japanese Pathologists. The World Health Organization classification of malignant lymphomas in Japan: Incidence of recently recognized entities. Pathol Int, 2000, 50:696-702.
12. Chang KC, Huang GC, Jones D, et al. Distribution and prognosis of WHO lymphoma subtypes in Taiwan reveals a low incidence of germinal-center derived tumors. Leukemia Lymphoma, 2004, 45:1375-1384.
13. Economopoulos T, Papageorgiou S, Dimopoulos MA, et al. Non-Hodgkin's lymphomas in Greece according to the WHO classification of lymphoid neoplasms. Aretrospective analysis of 810 cases. Acta Haematol, 2005, 113:97-103.
14. Lee SS, Cho KJ, Kim CW, et al. Clinicopathological analysis of 501 non-Hodgkin's lymphomas in Korea according to the revised European-American classification of lymphoid neoplasms. Histopathology, 1999, 35:345-354.
15. Savage KJ, Chhanabhai M, Gascoyne RD, et al. Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification. Ann Oncol, 2004, 15:1467-1475.
16. Au WY, Ma SY, Chim CS, et al. Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years. Ann Oncol, 2005, 16:206-214.
17. Attygalle A, Diss TC, Munson P, et al. CD10 expression in extranodal dissemination of angioimmunoblastic T-cell lymphoma. Am J Surg Pathol, 2004, 28:54-61.
18. Attygalle A, Al-Jehani R, Diss Tim, et al. Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood, 2002, 99:627-633.